Nivolumab in Relapsed Pediatric Solid Tumors
NCT02901145
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Antibodies, Neoplasm
Interventions
DRUG:
Nivolumab,low dose cyclophosphamide
Sponsor
Hadassah Medical Organization